Abstract Introduction The Coronavirus disease-19 (COVID-19) pandemic continues to
expand across the world. This pandemic has had a significant impact on patients with …

Abstract The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in
the city of Rotterdam, The Netherlands. The study aims to unravel etiology, preclinical …

Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving
disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine …

Background Influenza is an acutely debilitating respiratory infection, contributing significantly
to outpatient visits and hospitalizations. Spain lacks comprehensive and updated data on …

The infection of the central nervous system (CNS) with neurotropic viruses induces
neuroinflammation and is associated with the development of neuroinflammatory and …

Multiple Sclerosis (MS) is one of the immune‐mediated demyelinating disorders. Multiple
components, including the environment and genetics, are possible factors in the …

Background: Emergency hospital admissions are common in multiple sclerosis (MS), and
can highlight unmet medical needs. Objectives: To evaluate burden, predictors and …

Vaccines work by stimulating the immune system, and their immunogenicity is key in
achieving protection against specific pathogens. Questions have been raised whether in …

Background: Individuals with immune-mediated inflammatory diseases, such as
inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis, are at increased risk …

Background: The SARS-CoV-2 pandemic represents one of the most challenging issues that
have recently influenced everyday life in countries all over the world. Understanding the risk …